MvPI reviews 47,614 medical device associated adverse event cases in the past 10 years: Shardul Nautiyal, Mumbai Wednesday, October 29, 2025, 08:00 Hrs [IST] The Materiovigilance ...
Soleno Therapeutics posts Q3 profit as VYKAT XR adoption grows, doubling revenue. Learn about EU expansion plans, analyst concerns, and future outlook.
GAITHERSBURG, Md., US, November 7, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...
In both trials, TransCon PTH was generally well tolerated, with no new safety signals identified. Most treatment-emergent adverse events (TEAEs) were mild to moderate (Grade 1 or 2) and no patients ...
Emirates reports a reduction in severe turbulence events after introducing new data-driven tools to support pilot weather ...
NEW YORK, Nov. 5, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to a ruling in the litigation filed against the ...
Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.
Antibody-drug conjugates (ADCs) represent a new era in cancer therapy, harnessing the precision of antibodies to deliver ...
The transaction has been approved by the boards of directors of both companies and is currently expected to close in the quarter ending March 31, 2026, subject to Gulf Island shareholder approval, ...
Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court's decision denying Pfizer's request for a temporary restraining order to prevent Metsera, Inc.
Soleno Therapeutics (($SLNO)) has held its Q3 earnings call. Read on for the main highlights of the call. Soleno Therapeutics’ recent earnings ...
The Company still expects to issue its third quarter 2025 earnings release and financial supplement today after market. The Company is providing the following preliminary performance metrics: About ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results